Webdisclosure.com

Search

UCB (EBR:UCB) Transparency notification Vanguard Health Care Fund

Directive transparence : information réglementée

18/10/2019 20:00
https://u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W2= 7HkUdGSImvHQ6Hnxefh2lUknfK8X1nlXidSBcby8fJZ6lagmfqmYHWBPqjspbWRjPLXmteM7Hbz= -2Feb7iYUrzjqkD6ahJey4xD5TtfMN_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6= Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsABqSrA8n8O= CwBfIqlGq7MchK2VSAvyDg27BTMfb7TTsPhUSm8TqrM9GoWu-2B0Yszo3b7k9gnK0GU0X8JV0-2= BZ9cCe9hxWi-2BUCq9v7RpVVoalqS3Zsp3Fa0mGGRf33XEbmj8uCGFhTAGCrbE-2FfBinIpzRxX= 4qMI4UMq6ZNRB-2FD5o3OxSikDLR9vAp-2BCipJfVPGT4reSdr0U8SQAQpyYg8ynUGCdhdO0W-2= FUjlwDfynJ7K77l-2BdGeO0MumO-2BBAYCX-2B1Bn30-3D ** Transparency notification Vanguard Health Care Fund ------------------------------------------------------------ =C2=B7 Notification referring to situation on 1 October 2019 =C2=B7 Threshold crossed: 5% =C2=B7 Latest holding: 0.00%=C2=A0 Brussels (Belgium), 18 October 2019 =E2=80=93 20:00 (CEST) =E2=80=93 regula= ted information 1.=C2=A0=C2=A0Summary of the notification Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large = shareholdings, UCB SA/NV announces that it has received a transparency noti= fication from Vanguard Health Care Fund (having its registered office at c/= o The Vanguard Group, Inc. 400 Devon Park Drive, Wayne PA, 19087 USA), date= d 15 October 2019. Vanguard Health Care Fund, has notified that, following a disposal of votin= g rights, its holding of UCB shares with voting rights has decreased and ha= s crossed downwards the 5% threshold to 0.00% on 1 October 2019.=C2=A0 On 1 October 2019, Vanguard Health Care Fund, owned 0 UCB shares with votin= g rights (versus =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A09 741 353 = shares in its previous notification), representing 0.00% of the total numbe= r of shares issued by the company (194 505 658) (versus 5.01% in its previo= us notification). 2.=C2=A0=C2=A0Content of the notification =C2=B7 Reason for the notification: Acquisition or disposal of voting secur= ities or voting rights.=C2=A0 =C2=B7 Notification by: A person that notifies alone. =C2=B7 Person subject to the notification requirement:=C2=A0 https://u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W2= 7HkUdGSImvHQ6Hnxefh2lUknfK8X1nlXidSBcbyVa900AfFYODbCfPanN6CZsigkX8wJU4JFsY9= movIXrOrFN9tc05VojqH7mYelwmF_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr= 0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsABqSrA8n8OCw= BfIqlGq7MchK2VSAvyDg27BTMfb7TTsPhUSm8TqrM9GoWu-2B0Yszo3b7k9gnK0GU0X8JV0-2BZ= 9cCe9hxWi-2BUCq9v7RpVVoalqSwGZ7uI-2FVnI5Kh6jjslsa9rgZqqZNBcbSHpKPnYjk8ZXlAD= 9SuTC-2BLJGVOpgMMSE30WHjNVvjb2g1YqQDiuRnLx9yLgAOv-2Fo4-2Bqz6FP6pVV6H60U33bw= j3FFqXgNHMPNu8-2F-2BY79IdZ8jzhA0wvoeIcc-3D =C2=B7 Date on which the threshold is crossed: 1 October 2019. =C2=B7 Threshold crossed (in %): 5% =C2=B7 Denominator: 194 505 658. =C2=B7 Notified details: https://u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W2= 7HkUdGSImvHQ6Hnxefh2lUknfK8X1nlXidSBcbyIKhrVzz3h7HC1VdApvluE-2BBzyvxF-2BMuR= 4kB56BuBr8zaTOyH962hkd-2Fjugj3wP5z_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5Bwm= FRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsABqSrA= 8n8OCwBfIqlGq7MchK2VSAvyDg27BTMfb7TTsPhUSm8TqrM9GoWu-2B0Yszo3b7k9gnK0GU0X8J= V0-2BZ9cCe9hxWi-2BUCq9v7RpVVoalqS1lVI969zRF8QKys6HOwkNJtxETuMEboq36SkYbQhO3= Km8FouoNJafQjbC4Z7PKcAYaxoMIOB1CLwj1eeilqtLxNGRYWDlCmtp-2BWnDUCyXd4PewXM-2F= ZWEwTVwkK04yaLgTrpVeDIjJ6P-2B02fV8-2FzutM-3D =C2=B7 Chain of controlled undertakings through which the holding is effect= ively held: =E2=80=8B=E2=80=8BThe Vanguard Health Care Fund has thousands of shareholde= rs and no individual shareholder controls the fund.=C2=A0 =C2=B7 Additional information:=C2=A0 =E2=80=8B=E2=80=8B=E2=80=8BExternally managed Vanguard funds have granted p= roxy voting responsibilities to their portfolio managers effective 01 Octob= er 2019. 3.=C2=A0=C2=A0Further information=C2=A0 This press release and the detailed transparency notification are available= on UCB SA/NV=E2=80=99s website via the following link (https://u7061146.ct= .sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQB7X3kY45D7w88RKNKEbAnX0k= 168L1blu4vXqw-2F8RdooEQ6SU3zroSdeAFOVg4KQLSg-3D-3D_-2B-2Ft0TnE1oEbVIWS8vHM8= JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfL= oWbvi8z1TsABqSrA8n8OCwBfIqlGq7MchK2VSAvyDg27BTMfb7TTsPhUSm8TqrM9GoWu-2B0Ysz= o3b7k9gnK0GU0X8JV0-2BZ9cCe9hxWi-2BUCq9v7RpVVoalqS3yydk5roo6-2BWmKLqsqtTT2x1= XXGp0UFDoD3YC5xCTVHV2IbNVWD57RNiolw0n-2Bxn97-2B5zj1FFXz-2Flc4bxb4NgJHc3Cpnp= hCwcgTXQT7ai9c-2B376z-2F29pGtBhLEw-2B2yV3JXVLZAsEbAwanWdbnG4ujs-3D . An updated overview of the UCB SA/NV large shareholdings will be available = on UCB SA/NV=E2=80=99s website via the following link (https://u7061146.ct.= sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQB7X3kY45D7w88RKNKEbAnX0k1= 68L1blu4vXqw-2F8RdooEQ6SU3zroSdeAFOVg4KQLSg-3D-3D_-2B-2Ft0TnE1oEbVIWS8vHM8J= K8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLo= Wbvi8z1TsABqSrA8n8OCwBfIqlGq7MchK2VSAvyDg27BTMfb7TTsPhUSm8TqrM9GoWu-2B0Yszo= 3b7k9gnK0GU0X8JV0-2BZ9cCe9hxWi-2BUCq9v7RpVVoalqS6Ko14kOfzGxTZpywU4mEynC5xjj= 9C9xO0Sx53wnt9kvp1TmxkaqYMNAbwfvOJgsByT2pnrfoE-2Bs-2FFw5pU2xI1mmXXK5nsMo7Nw= PPNF2qa0Mm07pRFDLz-2BXpkvRyUwXAbJx5YZe-2B8lD5gvRM-2FZrEtvo-3D . Investor Relations Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 Investor Relations, UCB T +32.2.559.94.14 antje.witte@ucb.com Isabelle Ghellynck, =C2=A0Investor Relations, UCB T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0 About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company = focused on the discovery and development of innovative medicines and soluti= ons to transform the lives of people living with severe diseases of the imm= une system or of the central nervous system. With 7 500 people in approxima= tely 40 countries, the company generated revenue of =E2=82=AC 4.6 billion i= n 2018. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit= ter: @UCB_news =C2=A0 GenericFile 191018-Transparency notification press release Vanguard (https://u7061146.c= t.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W27HkUdGSImvHQ6Hnxef= h2lUknfK8X1nlXidSBcbyhGFPB9-2FT64NlH9P9sL4-2FYTs2j3c0W2InjJGthaPM1gY-3D_-2B= -2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7r= BLYSOuAKeTefElHQ9EZfLoWbvi8z1TsABqSrA8n8OCwBfIqlGq7MchK2VSAvyDg27BTMfb7TTsP= hUSm8TqrM9GoWu-2B0Yszo3b7k9gnK0GU0X8JV0-2BZ9cCe9hxWi-2BUCq9v7RpVVoalqSy9q5E= RJc08dZoYT-2BFOrz8Sb7L6gJ76Smlo7HiloGiOI2k6ZoLZnlL4G790UkiVGK4Gx2CpT99a-2Bh= u5B0nRQ7381OvZtu4vfY1PhXtIC6K-2BajH6Qk285igphBXj94aNnGO8nH7X-2BafuIpoPV9Zk8= R-2Bc-3D GenericFile 191018- Notification de transparence comm de presse Vanguard (https://u7061= 146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W27HkUdGSImvHQ6= Hnxefh2lUknfK8X1nlXidSBcby-2F4vLQCUw44XkI-2BeQIsRMVaj5TOVEwU7Jngmvqp9MjrI-3= D_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd= 9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsABqSrA8n8OCwBfIqlGq7MchK2VSAvyDg27BTMfb= 7TTsPhUSm8TqrM9GoWu-2B0Yszo3b7k9gnK0GU0X8JV0-2BZ9cCe9hxWi-2BUCq9v7RpVVoalqS= -2F2xDQdM4HJaQnThYhhfJptkfY23aJmIVBBD60zajXeS-2BtzI6WL0l483sQ6jQJxEEI2IHYR9= im-2FZeQb1oYBbbnnDsYj9yR6VZEPm86y3lNo-2FNkiWHq6jJVCg3Fn0Z4XwhbIKSbCF8rYIKcl= 23CtKcZ4-3D GenericFile 191018- Transparantieverklaring persbericht Vanguard (https://u7061146.ct.s= endgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W27HkUdGSImvHQ6Hnxefh2l= UknfK8X1nlXidSBcbyAd8zx-2BhYxilnS5RqdLjUXRWqh-2BGy4Sg3BQ9th03lnsY-3D_-2B-2F= t0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLY= SOuAKeTefElHQ9EZfLoWbvi8z1TsABqSrA8n8OCwBfIqlGq7MchK2VSAvyDg27BTMfb7TTsPhUS= m8TqrM9GoWu-2B0Yszo3b7k9gnK0GU0X8JV0-2BZ9cCe9hxWi-2BUCq9v7RpVVoalqS2Wk3HsuB= EKQLp7STL4-2BbfyyCMvAdfq7d0lvNW-2Fa7NDu7IAxAhlFEtJ24MZC6izYc7eq0UVAyx8PzLKR= oXxWotRERH3k2HPpJpnll7HnMrRNTLiEeCMGps1fvMq1-2FjDvqxOPZP2AQevBVGAcEmqFp24-3= D Image Chart 2 Transparency Oct 18 2019 (https://u7061146.ct.sendgrid.net/wf/click= ?upn=3DG62jSYfZdO-2F12d8lSllQBx1W27HkUdGSImvHQ6Hnxefh2lUknfK8X1nlXidSBcbyIK= hrVzz3h7HC1VdApvluEwGv31CqPHODN9ryEF1-2F8I4-3D_-2B-2Ft0TnE1oEbVIWS8vHM8JK8e= u8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbv= i8z1TsABqSrA8n8OCwBfIqlGq7MchK2VSAvyDg27BTMfb7TTsPhUSm8TqrM9GoWu-2B0Yszo3b7= k9gnK0GU0X8JV0-2BZ9cCe9hxWi-2BUCq9v7RpVVoalqS1TwJcdwu89j0nLSp9yLK4G0H090cuw= 3F-2BeFHhYu7CSlhY-2FW0E2UQoTgr77O5X6DhDLG-2FISDcCKBwGpyrdGsxyNeDx8xR1Iw214X= 8w1lSLx21zQEo4sPntARPj5yxwnxLjq-2F-2BRS44JPgwPiJF-2FD-2BK1I-3D Image Chart 1 Transparency Oct 18 2019 (https://u7061146.ct.sendgrid.net/wf/click= ?upn=3DG62jSYfZdO-2F12d8lSllQBx1W27HkUdGSImvHQ6Hnxefh2lUknfK8X1nlXidSBcbyVa= 900AfFYODbCfPanN6CZt7ZwHwF2Mthw6my8uTVZI8-3D_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8= RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8= z1TsABqSrA8n8OCwBfIqlGq7MchK2VSAvyDg27BTMfb7TTsPhUSm8TqrM9GoWu-2B0Yszo3b7k9= gnK0GU0X8JV0-2BZ9cCe9hxWi-2BUCq9v7RpVVoalqS3Xijwpfa5z2a6AAbK7nJ9Da8bA-2BZyi= RHmj0Fl351jmNQdBbW-2BoXqoBh38iaFwS9jpud3N5WbbenWsVpq3mLtSODIYBL-2FDfhcgOxVQ= GuTQAzVKgb4RMhCCAns2eJ-2FlEk0K7M7i8sG4AMft50RnhedTk-3D=0D =0D ______________________=0D If you would rather not receive future communications from UCB SA, please g= o to https://u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQ= Bz2p53T0v-2BoEIvbo6vDi8C-2BOyFzyb6obo-2BzKSgNKq4mrJndRzNm0B2vCg5H-2FFVO-2Fw= Ba0AKLe-2FguNnZjntqFa7qXeqq5HLiyhFbMyuw2uOWMQAuzHELm0ox4y35Sy1I1EUJ28pydK0H= I-2F2BR6RFaOTCU-3D_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQq= ZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsABqSrA8n8OCwBfIqlGq7Mc= hK2VSAvyDg27BTMfb7TTsPhUSm8TqrM9GoWu-2B0Yszo3b7k9gnK0GU0X8JV0-2BZ9cCe9hxWi-= 2BUCq9v7RpVVoalqSxBaYrbAgpgW82Zrux1QmvqdBE7jkAvonmhGL6z61rjFJhalDmsPvId0NmA= g-2FUVUSuqtvZRTO-2BM2Gzkh55f0lkeA5PrNU3cg1qRCgXD6RzJlY6UrV14kRQWK67Vef6LDA5= nmAezXVbMLTTYIRG08XIk-3D=0D UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=

25/11/2019 13:31
15/11/2019 07:01
08/11/2019 20:00
08/11/2019 07:01
08/11/2019 07:01
08/11/2019 07:00
18/10/2019 20:00
18/10/2019 07:00
17/10/2019 07:00
11/10/2019 20:01